Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Global Health|January 16, 2019
Explaining progress towards Millennium Development Goal 4 for child survival in TanzaniaDebora Niyeha, Deogratius Malamsha, Rose Mpembeni, et al.
Rheumatology (Oxford, England)|June 4, 2021
Barriers and facilitators to influenza and pneumococcal vaccine hesitancy in rheumatoid arthritis: a qualitative studyInés Colmegna, Valeria Valerio, Vincent Gosselin-Boucher, et al.
The Journal of Rheumatology|March 3, 2016
How to Attract Trainees, a Pan-Canadian Perspective: Phase 1 of the "Training the Rheumatologists of Tomorrow" ProjectAlfred Cividino, Volodko Bakowsky, Susan Barr, et al.
Pediatric Rheumatology Online Journal|June 6, 2021
Development and validation of the RACER (Readiness for Adult Care in Rheumatology) transition instrument in youth with juvenile idiopathic arthritisLynn Spiegel, Lori Tucker, Karen Watanabe Duffy, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 15, 2013
Assessing process of care in rheumatoid arthritis at McGill University hospitalsLisa Marina Li, Basile Tessier-Cloutier, Yafei Wang, et al.
The Journal of Allergy and Clinical Immunology|July 15, 2009
Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16Jennifer P DeMore, Elizabeth H Weisshaar, Rose F Vrtis, et al.
Lancet (London, England)|October 20, 2015
Countdown to 2015: a decade of tracking progress for maternal, newborn, and child survivalCesar G Victora, Jennifer Harris Requejo, Aluisio J D Barros, et al.
The American Journal of Tropical Medicine and Hygiene|January 21, 2016
Independent Evaluation of the integrated Community Case Management of Childhood Illness Strategy in Malawi Using a National Evaluation Platform DesignAgbessi Amouzou, Mercy Kanyuka, Elizabeth Hazel, et al.
RMD Open|November 29, 2023
COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary seriesInes Colmegna, Valeria Valerio, Nathalie Amiable, et al.
BMJ Global Health|May 21, 2024
Challenges in reducing maternal and neonatal mortality in Niger: an in-depth case studyAlmamy Malick Kante, Lamou Ousseini Youssoufa, Aida Mounkaila, et al.
Pageof 5